Drugplain

CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment 20 mg/mL

Salicylic acid · LIQUID · L'Oreal USA Products Inc

No Recall History
Plain English

CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment is a liquid containing salicylic acid at 20 mg/mL, taken topical. Manufactured by L'Oreal USA Products Inc.

Key Facts

Brand Name
CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
Generic Name
Salicylic acid
NDC Code (Product)
82046-291
Manufacturer
L'Oreal USA Products Inc
Strength
20 mg/mL
Dosage Form
LIQUID
Route
TOPICAL
Marketing Status
Application #
M006
Marketing Start
05/19/2026

Recall History

No Recall History

Frequently Asked Questions

What is CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment used for?

CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment contains Salicylic acid. It is a liquid taken topical. Consult your doctor for specific uses.

Is CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment a controlled substance?

CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment is not classified as a controlled substance by the DEA.

What is the generic name for CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment?

The generic name for CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment is Salicylic acid. There are 12 other brand versions of Salicylic acid.

What is the NDC code for CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment 20 mg/mL?

The NDC (National Drug Code) for CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment 20 mg/mL is 82046-291, listed by L'Oreal USA Products Inc.